[go: up one dir, main page]

NO20052884L - Substituerte indolpyridinforbindelser som anti-infeksjonsmidler. - Google Patents

Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.

Info

Publication number
NO20052884L
NO20052884L NO20052884A NO20052884A NO20052884L NO 20052884 L NO20052884 L NO 20052884L NO 20052884 A NO20052884 A NO 20052884A NO 20052884 A NO20052884 A NO 20052884A NO 20052884 L NO20052884 L NO 20052884L
Authority
NO
Norway
Prior art keywords
indolpyridine
substituted
compounds
infective agents
infective
Prior art date
Application number
NO20052884A
Other languages
English (en)
Other versions
NO20052884D0 (no
Inventor
Piet Tom Bert Paul Wigerinck
Dominique Louis Nest Surleraux
Bart Rudolf Romanie Kesteleyn
Dirk Edward Desire Jochmans
Abdellah Tahri
Wim Van De Vreken
Natalie Maria Franc Kindermans
Maxime Francis Jean-Mar Canard
Kurt Hertogs
Eva Bettens
Veronique Corine Paul De Vroey
Jing Wang
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of NO20052884D0 publication Critical patent/NO20052884D0/no
Publication of NO20052884L publication Critical patent/NO20052884L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

2005 -07- 2 9 Sammendrag 0. nr. E40674 Foreliggende oppfinnelse angår nye pyridazinonderivater.
NO20052884A 2002-11-15 2005-06-14 Substituerte indolpyridinforbindelser som anti-infeksjonsmidler. NO20052884L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02079783 2002-11-15
US43495002P 2002-12-20 2002-12-20
PCT/EP2003/050837 WO2004046143A1 (en) 2002-11-15 2003-11-14 Substituted indolepyridinium as anti-infective compounds

Publications (2)

Publication Number Publication Date
NO20052884D0 NO20052884D0 (no) 2005-06-14
NO20052884L true NO20052884L (no) 2005-08-15

Family

ID=32327852

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052884A NO20052884L (no) 2002-11-15 2005-06-14 Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.

Country Status (16)

Country Link
US (2) US7608726B2 (no)
EP (1) EP1594870B1 (no)
JP (1) JP2006508145A (no)
KR (1) KR20050084621A (no)
CN (1) CN100457754C (no)
AP (1) AP1927A (no)
AU (1) AU2003296760B2 (no)
BR (1) BR0316209A (no)
CA (1) CA2506316A1 (no)
EA (1) EA009871B1 (no)
HR (1) HRP20050543A2 (no)
MX (1) MXPA05005146A (no)
NO (1) NO20052884L (no)
NZ (1) NZ540321A (no)
PL (1) PL376683A1 (no)
WO (1) WO2004046143A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
TW200607502A (en) * 2004-05-17 2006-03-01 Tibotec Pharm Ltd 6, 7, 8, 9-substituted 1-phenyl-1, 5-dihydro-pyrido[3, 2-b]indol-2-ones
MXPA06013314A (es) * 2004-05-17 2007-02-02 Tibotec Pharm Ltd 1-heterociclil-1,5-dihidro-pirido[3,2-b]indol-2-onas.
US20070238727A1 (en) * 2004-05-17 2007-10-11 Tibotec Bvba 5-Substituted 1-Phenyl-1,5-Dihydro-Pyrido[3,2-B]Indol-2-Ones and Analogs as Anti-Virals
CN1953751A (zh) * 2004-05-17 2007-04-25 泰博特克药品有限公司 取代的1－苯基－1,5－二氢－吡啶并－[3,2－b]吲哚－2－酮和其它的hiv抑制剂的组合物
US7622582B2 (en) 2004-05-17 2009-11-24 Tibotec Bvba Derivatives of 1-phenyl-benzofuro[3,2]pyridin-2(1H)-one
ES2380631T3 (es) 2004-09-30 2012-05-17 Tibotec Pharmaceuticals Pirimidinas sustituidas en posición 5 inhibidoras de VIH
WO2006035067A2 (en) 2004-09-30 2006-04-06 Tibotec Pharmaceuticals Ltd. Hiv inhibiting 5-heterocyclyl pyrimidines
TW200637862A (en) * 2005-01-10 2006-11-01 Tibotec Pharm Ltd 1,5,6-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes
WO2006082250A1 (en) * 2005-02-04 2006-08-10 Tibotec Pharmaceuticals Ltd. Screening method for competitive hiv rt inhibitors
US20090012046A1 (en) * 2006-02-03 2009-01-08 Dirk Edward Desire Jochmans Methods of Treating Mutated Hiv
WO2007113254A1 (en) 2006-03-30 2007-10-11 Tibotec Pharmaceuticals Ltd. Hiv inhibiting 5-amido substituted pyrimidines
WO2008037783A1 (en) * 2006-09-29 2008-04-03 Tibotec Pharmaceuticals Ltd. Process for preparing 2-oxo-2,5-dihydro-1h-pyrido[3,2-b]indole-3-carbonitriles
WO2008080965A2 (en) 2006-12-29 2008-07-10 Tibotec Pharmaceuticals Ltd. Hiv inhibiting 5,6-substituted pyrimidines
JP5185283B2 (ja) 2006-12-29 2013-04-17 テイボテク・フアーマシユーチカルズ Ｈｉｖ阻害６−置換ピリミジン
AR065720A1 (es) 2007-03-14 2009-06-24 Tibotec Pharm Ltd Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso.
AU2008274185B2 (en) 2007-07-12 2014-07-03 Janssen Sciences Ireland Uc Crystalline form of (E) 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile
JP2012515789A (ja) 2009-01-23 2012-07-12 ブリストル−マイヤーズ スクイブ カンパニー スフィンゴシン−１−リン酸アゴニストとしてのピラゾール−１，２，４−オキサジアゾール誘導体
EP2382212B1 (en) 2009-01-23 2014-07-16 Bristol-Myers Squibb Company Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
CN102361869A (zh) 2009-01-23 2012-02-22 百时美施贵宝公司 在治疗自身免疫性疾病和炎性疾病中作为s1p激动剂的取代的噁二唑衍生物
KR20120034592A (ko) 2009-04-09 2012-04-12 베링거 인겔하임 인터내셔날 게엠베하 Ｈｉｖ 복제의 저해제
EP2386541A1 (en) * 2010-05-14 2011-11-16 Affectis Pharmaceuticals AG Novel methods for the preparation of P2X7R antagonists
WO2012014760A1 (ja) 2010-07-28 2012-02-02 住友化学株式会社 カルボン酸アミドの製造方法
UA115576C2 (uk) 2012-12-06 2017-11-27 Байєр Фарма Акцієнгезелльшафт Похідні бензимідазолу як антагоністи ер4
JP6930972B2 (ja) * 2015-12-02 2021-09-01 シンジェンタ パーティシペーションズ アーゲー 殺微生物性オキサジアゾール誘導体
US11066396B2 (en) * 2016-06-23 2021-07-20 Merck Sharp & Dohme Corp. 3-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetylase 6 (HDAC6) inhibitors
KR200486209Y1 (ko) 2016-07-05 2018-04-16 박우 편육 가공기구
CN108299428B (zh) * 2018-04-04 2019-09-27 山东大学 8-胺基-7-甲酸甲酯-吡嗪骈吡啶酮衍生物及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055520A2 (en) * 2000-12-18 2002-07-18 Us Health Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2002246659A1 (en) * 2000-12-18 2002-08-06 The Government Of The United States Of America, As Represented By The Secretary, Department Of Healt Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds

Also Published As

Publication number Publication date
NZ540321A (en) 2007-09-28
HRP20050543A2 (en) 2006-09-30
EP1594870A1 (en) 2005-11-16
WO2004046143A1 (en) 2004-06-03
CN100457754C (zh) 2009-02-04
EA200500822A1 (ru) 2005-12-29
AP1927A (en) 2008-12-10
KR20050084621A (ko) 2005-08-26
NO20052884D0 (no) 2005-06-14
CA2506316A1 (en) 2004-06-03
CN1738816A (zh) 2006-02-22
US20100048563A1 (en) 2010-02-25
US20060173000A1 (en) 2006-08-03
MXPA05005146A (es) 2005-07-22
PL376683A1 (pl) 2006-01-09
JP2006508145A (ja) 2006-03-09
AU2003296760A1 (en) 2004-06-15
EA009871B1 (ru) 2008-04-28
AU2003296760B2 (en) 2009-11-19
EP1594870B1 (en) 2011-05-11
US7608726B2 (en) 2009-10-27
AP2005003334A0 (en) 2005-06-30
BR0316209A (pt) 2005-09-27

Similar Documents

Publication Publication Date Title
NO20052884L (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
DE60230890D1 (de) Indolizine als kinaseproteinhemmer
CY1110064T1 (el) Παραγωγα φαινυλ-πιπεραζινης ως αναστολεις επαναπροσληψης σεροτονινης
SE0203713D0 (sv) Novel compounds
HRP20120323T1 (en) Diarylhydantoin compounds
DK1337518T3 (da) Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren
CY1113578T1 (el) 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
DK1483265T3 (da) Purinderivater som kinaseinhibitorer
EA200500017A1 (ru) Новые соединения
BRPI0414593A (pt) derivados de ácido sulfonamida substituìda-indol-2-carboxìlico como inibidores de pai-1
DK1379239T3 (da) N(2-aryl-ethyl)-benzyl-aminer som antagonister af 5 HT6 receptoren
SE0303180D0 (sv) Novel compounds
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
SE0302232D0 (sv) Novel Compounds
CY1105994T1 (el) Aναδιαταγμενες πεντανολες, μεθοδος για την παραγωγη αυτων και η χρηση αυτων ως αντιφλεγμονωδων
ATE438398T1 (de) Pyrrolo-dihydroisochinolin-derivate als pde10- inhibitoren
SE0103710D0 (sv) Compounds
NO20054787D0 (no) Indenderivater som farmasotiske midler
BR0208812A (pt) Derivados fenil heterociclil éter como inibidores de recaptação de serotonina
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
DK1658062T3 (da) Alfa-aminoamid-derivater anvendelige som anti-inflammatoriske midler
NO20063293L (no) Farmasoytiske forbindelser
EA200400822A1 (ru) Производные 3,4-дигидро-1h-изохинолин-2-ила

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application